Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-25T14:02:06.443Z Has data issue: false hasContentIssue false

Chapter 11 - Botulinum neurotoxin therapy of laryngeal muscle hyperactivity syndromes

Published online by Cambridge University Press:  05 February 2014

By
Daniel Truong ,
Arno Olthoff  and
Rainer Laskawi
Edited by
Daniel Truong ,
Dirk Dressler ,
Mark Hallett  and
Christopher Zachary
Daniel Truong
Affiliation:
The Parkinson’s and Movement Disorders Institute, Fountain Valley, California
Arno Olthoff
Affiliation:
Department of Phoniatrics and Pediatric Audiology, University of Göttingen, Göttingen, Germany
Rainer Laskawi
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, University of Göttingen, Göttingen, Germany
Daniel Truong
Affiliation:
The Parkinson’s and Movement Disorders Institute, Fountain Valley, California
Dirk Dressler
Affiliation:
Department of Neurology, Hannover University Medical School
Mark Hallett
Affiliation:
George Washington University School of Medicine and Health Sciences, Washington, DC
Christopher Zachary
Affiliation:
Department of Dermatology, University of California, Irvine
Get access

Summary

Introduction

Spasmodic dysphonia is a focal dystonia characterized by task-specific, action-induced spasm of the vocal cords. It adversely affects a patient’s ability to communicate. It can occur independently, as part of cranial dystonia (Meige’s syndrome), or in other disorders such as in tardive dyskinesia.

Clinical features

There are three types of spasmodic dysphonia: the adductor type, the abductor type and the mixed type:

  • adductor spasmodic dysphonia (ADSD) is characterized by a strained-strangled voice quality and intermittent voice stoppage or breaks, resulting in a staccato-like voice, caused by overadduction of the vocal folds

  • abductor spasmodic dysphonia (ABSD) is characterized by intermittent breathy breaks and associated with prolonged abduction folds during voiceless consonants in speech

  • patients with the mixed type have presentations of both.

Symptoms of spasmodic dysphonia begin gradually over several months to years. The condition typically affects patients in their mid-forties and is more common in women (Adler et al., 1997; Schweinfurth et al., 2002).

Type
Chapter
Information
Manual of Botulinum Toxin Therapy , pp. 85 - 91
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adler, CH, Edwards, BW, Bansberg, SF (1997). Female predominance in spasmodic dysphonia. J Neurol Neurosurg Psychiatry, 63, 688.CrossRefGoogle ScholarPubMed
Adler, CH, Bansberg, SF, Hentz, JG et al. (2004a). Botulinum toxin type A for treating voice tremor. Arch Neurol, 61, 1416–20.CrossRefGoogle ScholarPubMed
Adler, CH, Bansberg, SF, Krein-Jones, K, Hentz, JG (2004b). Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia. Mov Disord, 19, 1075–9.CrossRefGoogle Scholar
Aronson, AE, Brown, JR, Litin, EM, Pearson, JS (1968). Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias. J Speech Hear Disord, 33, 219–31.CrossRefGoogle ScholarPubMed
Bielamowicz, S, Stager, SV, Badillo, A, Godlewski, A (2002). Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia. J Voice, 16, 117–23.CrossRefGoogle ScholarPubMed
Blitzer, A, Sulica, L (2001). Botulinum toxin basic science and clinical uses in otolaryngology. Laryngoscope 111, 218–26.CrossRefGoogle ScholarPubMed
Blitzer, A, Brin, MF, Stewart, C, Aviv, JE, Fahn, S (1992). Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope, 102, 163–7.CrossRefGoogle ScholarPubMed
Brin, MF, Fahn, S, Moskowitz, C et al. (1988a). Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Adv Neurol, 50, 599–608.Google ScholarPubMed
Brin, MF, Blitzer, A, Stewart, C (1988b). Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol, 78, 237–52.Google Scholar
Brin, MF, Blitzer, A, Fahn, S, Gould, W, Lovelace, RE (1989). Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Mov Disord, 4, 287–96.CrossRefGoogle Scholar
Ford, CN, Bless, DM, Lowery, JD (1990). Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg, 103, 752–8.CrossRefGoogle ScholarPubMed
Green, DC, Berke, GS, Ward, PH, Gerratt, BR (1992). Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Ann Otol Rhinol Laryngol, 101, 883–7.CrossRefGoogle ScholarPubMed
Guntinas-Lichius, O (2003). Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A. Laryngoscope, 113, 743–5.CrossRefGoogle ScholarPubMed
Klotz, DA, Maronian, NC, Waugh, PF et al. (2004). Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography. Ann Otol Rhinol Laryngol, 113, 602–12.CrossRefGoogle Scholar
Koda, J, Ludlow, CL (1992). An evaluation of laryngeal muscle activation in patients with voice tremor. Otolaryngol Head Neck Surg, 107, 684–96.CrossRefGoogle ScholarPubMed
Ludlow, CL, Naunton, RF, Sedory, SE, Schulz, GM, Hallett, M (1988). Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology, 38, 1220–5.CrossRefGoogle ScholarPubMed
Meleca, RJ, Hogikyan, ND, Bastian, RW (1997). A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia. Otolaryngol Head Neck Surg, 117, 487–92.CrossRefGoogle ScholarPubMed
Miller, RH, Woodson, GE, Jankovic, J (1987). Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg, 113, 603–5.CrossRefGoogle ScholarPubMed
Rhew, K, Fiedler, DA, Ludlow, CL (1994). Technique for injection of botulinum toxin through the flexible nasolaryngoscope. Otolaryngol Head Neck Surg, 111, 787–94.CrossRefGoogle ScholarPubMed
Sapienza, CM, Walton, S, Murry, T (2000). Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading. J Voice, 14, 502–20.CrossRefGoogle Scholar
Schönweiler, R, Wohlfarth, K, Dengler, R, Ptok, M (1998). Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction. Laryngoscope, 108, 55–63.CrossRefGoogle ScholarPubMed
Schweinfurth, JM, Billante, M, Courey, MS (2002). Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope, 112, 220–23.CrossRefGoogle ScholarPubMed
Truong, D, Bhidayasiri, R (2006) Botulinum toxin in laryngeal dystonia. Eur J Neurol, 13(Suppl 1), 36–41.CrossRefGoogle Scholar
Truong, DD, Rontal, M, Rolnick, M, Aronson, AE, Mistura, K (1991). Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope, 101, 630–4.CrossRefGoogle Scholar
Zwirner, P, Dressler, D, Kruse, E (1997). Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol, 254, 242–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×